# Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients

> **NCT00962585** · PHASE2 · COMPLETED · sponsor: **Ausio Pharmaceuticals, LLC** · enrollment: 169 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Placebo
- **DRUG:** S-equol

## Key facts

- **NCT ID:** NCT00962585
- **Lead sponsor:** Ausio Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 169 (ACTUAL)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00962585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00962585, "Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00962585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*